Project Details
Description
Malaria is a major global health issue affecting over half a billion people and
resulting in 3-5 million deaths annually. This disease is caused by parasites of the genus
Plasmodium with P. falciparum being the most lethal species. The host-pathogen
relationship between Plasmodium and the host red blood cell is responsible for all
clinical manifestations of the malaria disease and is a continuous 48-hour cycle that can
be faithfully reproduced in the laboratory. Despite over a century of research on malaria,
it continues to be a major health problem largely because drug-resistant parasites are on
the rise, circumventing long-efficacious drug treatments. Thus, there is a renewed
urgency to identify novel chemotherapeutics to treat this disease.
This proposal aims to provide the first global analysis of the metabolic
host-pathogen interactions for Plasmodium falciparum as a means to
identify novel drug targets. The metabolic pathways encoded in any pathogen
genome define the repertoire of chemical processes that it can autonomously regulate.
All other metabolites must be taken up from the host cell or metabolized from precursors
available through the host. Therefore, the host cell and pathogen are intimately linked
through the reliance of the pathogen on the host for nutrients. The genome of P.
falciparum suggests that this organism is biochemically unique: 60% of its genome
encodes proteins never seen before in biology, and the remaining 40% contains very few
of the fundamental metabolic genes found in almost all other eukaryotes. This indicates
that the mechanism of interaction between Plasmodium and the host red blood cell may
reveal novel metabolic enzymes that can provide new targets for pharmacological
intervention. Using recently developed mass spectrometry techniques, we will
quantitate metabolites in Plasmodium-infected cells and integrate these and other data
to generate network interaction models revealing new biological insights into this deadly
pathogen.
Status | Finished |
---|---|
Effective start/end date | 9/30/07 → 8/31/12 |
Funding
- NIH Office of the Director: $2,370,000.00
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.